- Report
- August 2025
- 188 Pages
Global
From €3471EUR$3,939USD£3,022GBP
- Report
- September 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,444GBP
- Report
- January 2026
- 184 Pages
Global
From €3471EUR$3,939USD£3,022GBP
- Report
- January 2026
- 193 Pages
Global
From €3471EUR$3,939USD£3,022GBP
- Report
- January 2026
- 196 Pages
Global
From €3471EUR$3,939USD£3,022GBP
- Report
- January 2026
- 181 Pages
Global
From €3471EUR$3,939USD£3,022GBP
- Report
- January 2026
- 139 Pages
Global
From €5156EUR$5,850USD£4,487GBP
- Report
- September 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,444GBP
- Report
- September 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,444GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1102EUR$1,250USD£959GBP
- Report
- March 2024
- 159 Pages
Global
From €7006EUR$7,950USD£6,098GBP
- Report
- January 2026
- 50 Pages
Global
From €2335EUR$2,650USD£2,033GBP
- Report
- January 2026
- 50 Pages
Global
From €2335EUR$2,650USD£2,033GBP
- Report
- January 2026
- 50 Pages
Global
From €2335EUR$2,650USD£2,033GBP

Propranolol is a beta-blocker drug used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, that affect the heart and blood vessels. Propranolol is also used to treat certain types of tremors, and to prevent migraine headaches. It is available in both oral and intravenous forms.
Propranolol is one of the most commonly prescribed cardiovascular drugs, and is widely used in the treatment of hypertension, angina, and arrhythmias. It is also used to treat certain types of tremors, and to prevent migraine headaches. It is generally well tolerated, with few side effects.
The propranolol market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more